Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical impact of and microbiological risk factors for qacA/B positivity in ICU-acquired ST5-methicillin-resistant SCCmec type II Staphylococcus aureus bacteremia.

Autor: Kim, Haein¹ (AUTHOR), Park, Sunghee¹ (AUTHOR), Seo, Hyeonji¹ (AUTHOR), Chung, Hyemin¹ (AUTHOR), Kim, Eun Sil^1,2 (AUTHOR), Sung, Heungsup³ (AUTHOR), Kim, Mi-Na³ (AUTHOR), Bae, Seongman¹ (AUTHOR), Jung, Jiwon¹ (AUTHOR), Kim, Min Jae¹ (AUTHOR), Kim, Sung-Han¹ (AUTHOR), Lee, Sang-Oh¹ (AUTHOR), Choi, Sang-Ho¹ (AUTHOR), Kim, Yang Soo¹ (AUTHOR), Chong, Yong Pil¹ (AUTHOR) drchong@amc.seoul.kr

Publikováno v: Scientific Reports. 7/6/2022, Vol. 12 Issue 1, p1-9. 9p.

Clinical and Microbiological Risk Factors for Community-Associated Clostridioides difficile Infections

Autor: Young Ah Kim, Heejung Kim, Dokyun Kim, Changseung Liu, Seok Hoon Jeong

Publikováno v: Annals of Clinical Microbiology, Vol 25, Iss 2, Pp 53-58 (2022)

Background: The incidence of community-associated (CA) Clostridioides difficile infection (CDI) has increased in Korea. In this study, we evaluated CA-CDI risk factors in terms of clinical features and ribotype considering its region-specific molecul

Externí odkaz: https://doaj.org/article/ce3f089317c74c318982c6780e449fa1

Clinical and Microbiological Risk Factors for Severe Clostridioides difficile Infections

Autor: Young Ah Kim, Heejung Kim, Dokyun Kim, Changseung Liu, Seok Hoon Jeong

Publikováno v: Annals of Clinical Microbiology, Vol 25, Iss 1, Pp 21-28 (2022)

Background: There has been a marked increase in the mortality rate associated with Clostridioides difficile infection (CDI) globally since 2003, with the emergence of binary toxinproducing ribotype 027 strains. However, the molecular epidemiology o

Externí odkaz: https://doaj.org/article/ef00d4cc3b444b11a328fa25b61da917

Clinical and Microbiological Risk Factors for 30-Day Mortality of Bloodstream Infections Caused by OXA-48-Producing Klebsiella pneumoniae .

Autor: Lumbreras-Iglesias P; Traslational Microbiology Group, Health Research Institute of the Principality of Asturias (ISPA), 33011 Oviedo, Spain.; Department of Clinical Microbiology, Central University Hospital of Asturias (HUCA), 33011 Oviedo, Spain.; Hematological Malignancies Group, Health Research Institute of the Principality of Asturias (ISPA), 33011 Oviedo, Spain., Rodrigo-Arrazola E; Department of Clinical Microbiology, Central University Hospital of Asturias (HUCA), 33011 Oviedo, Spain., López-Amor L; Department of Intensive Care Medicine, San Agustín University Hospital (HUSA), 33401 Avilés, Spain., Fernández-Suárez J; Traslational Microbiology Group, Health Research Institute of the Principality of Asturias (ISPA), 33011 Oviedo, Spain.; Department of Clinical Microbiology, Central University Hospital of Asturias (HUCA), 33011 Oviedo, Spain., Rodicio MR; Traslational Microbiology Group, Health Research Institute of the Principality of Asturias (ISPA), 33011 Oviedo, Spain.; Department of Functional Biology, Microbiology Area, University of Oviedo, 33006 Oviedo, Spain., Fernández J; Traslational Microbiology Group, Health Research Institute of the Principality of Asturias (ISPA), 33011 Oviedo, Spain.; Department of Clinical Microbiology, Central University Hospital of Asturias (HUCA), 33011 Oviedo, Spain.; Department of Functional Biology, Microbiology Area, University of Oviedo, 33006 Oviedo, Spain.; Research & Innovation, Artificial Intelligence and Statistical Department, Pragmatech AI Solutions, 33001 Oviedo, Spain.; Biomedical Research Networking Center-Respiratory Diseases, 28029 Madrid, Spain.

Publikováno v: Pathogens (Basel, Switzerland) [Pathogens] 2023 Dec 21; Vol. 13 (1). Date of Electronic Publication: 2023 Dec 21.